FDA NDC Directory · JSON-LD · Markdown

Praxbind

NDC 0597-0197 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic nameidarucizumab
Labeler / ManufacturerBoehringer Ingelheim Pharmaceuticals, Inc.
Marketing categoryBiologic License Application · App BLA761025
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsIDARUCIZUMAB (50 mg/mL)
Marketing started20151021
Package count1

External sources

Source: openFDA. Public-domain (CC0).